Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
Title:
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
Author:
Poynard, Thierry Marcellin, Patrick Lee, Samuel S Niederau, Christian Minuk, Gerald S Ideo, Gaetano Bain, Vincent Heathcote, Jenny Zeuzem, Stefan Trepo, Christian Albrecht, Janice